39 results
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... with epidemic risk ... Trypanosomiasis #IDSA ... #management #opportunistic ... #infections #HIVAIDS
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Outpatient Treatment ... comorbidities or risk ... fluoroquinolone #IDSA ... #Antibiotics #Treatment ... #Regimen #Management
2 Percent MACE Image - After calculating the risk for acute coronary syndrome, select the corresponding
calculating the risk ... (i.e. highest) risk ... representing 2% risk ... #Management #PatientInfo ... #Cardiology #ChestPain
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... Meningoencephalitis #IDSA ... #Treatment #management ... #cryptococcus #HIVAIDS
1 Percent MACE Image - After calculating the risk for acute coronary syndrome, select the corresponding
calculating the risk ... (i.e. highest) risk ... representing 2% risk ... #Management #PatientInfo ... #Cardiology #ChestPain
3 Percent MACE Image - After calculating the risk for acute coronary syndrome, select the corresponding
calculating the risk ... (i.e. highest) risk ... representing 2% risk ... #Management #PatientInfo ... #Cardiology #ChestPain
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Penicilliosis #IDSA ... #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS
Candidemia Workup and Management - IDSA Guidelines
1) Antibiotics
 • Empiric: Echinocandins (e.g. micafungin) for most patients
Candidemia Workup and Management ... - IDSA Guidelines ... Other hardware - Risk-Benefit ... #Candidemia #IDSA ... #candidiasis #treatment
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... for effective treatment ... candida #mucosal #IDSA ... #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... HumanPapillomavirus #IDSA ... #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS